PA
FLS icon

PharVision Advisers’s Flowserve FLS Stock Holding History

PharVision Advisers’s Portfolio FLS Stock Details FLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,924
Closed -$411K – 303
2025
Q4 		$411K Buy
5,924
+448
+8% +$28.8K 0.21% 112
2025
Q3 		$291K Buy
+5,476
New +$297K 0.16% 241
2025
Q2 		– Sell
-8,015
Closed -$391K – 329
2025
Q1 		$391K Buy
8,015
+4,417
+123% +$251K 0.54% 37
2024
Q4 		$207K Buy
+3,598
New +$206K 0.18% 290

Other funds holding FLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
DCP
D1 Capital Partners New York $34.8B AUM 11.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

PharVision Advisers's FLS Position: Q1 2026 in Review

PharVision Advisers sold out of Flowserve (FLS) in Q1 2026, closing a stake of 5,924 shares — an estimated $411K sold.

PharVision Advisers first reported a position in FLS in Q4 2024 and held it in 4 quarters. The position peaked at $411K in Q4 2025. 623 funds tracked by Wall St. Rank hold FLS as of Q1 2026.

  • PharVision Advisers reported no remaining Flowserve position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 5,924 Flowserve shares in Q1 2026, an estimated $411K.
  • PharVision Advisers first reported a position in Flowserve in Q4 2024 and held it in 4 quarters.
  • PharVision Advisers's Flowserve position peaked at $411K in Q4 2025.
  • 623 funds tracked by Wall St. Rank held Flowserve as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.